WAVE Life Sciences Discloses 'Positive' Data From Phase 1b/2a Trial of WVE-003 to Treat Huntington's Disease
WAVE Life Sciences Discloses 'Positive' Data From Phase 1b/2a Trial of WVE-003 to Treat Huntington's Disease
Wave Life Sciences公佈WVE-003治療亨廷頓病1b/2a臨床試驗的“積極”數據
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊